Ibogaine is a naturally occurring medication obtained from the root bark of the shrub Tabernanthe iboga. This shrub grows in Gabon and other Central West African countries. The ibogaine root bark has been used in these countries for hundreds to thousands of years during the ritualistic ceremonies of the Bwiti religion.
Ibogaine displays anti-addictive properties, interrupting the symptoms of the drug withdrawal syndrome and reducing drug craving for extended periods of time — allowing an addict to detoxify with minimal symptoms. Ibogaine also appears to reset the brain’s neurotransmitter function to a pre-addictive state. Ibogaine has been, and is now currently again being, studied at the University of Miami in an FDA approved Phase 1 clinical trial.
At the Pangea Biomedics we administer ibogaine hydrochloride (98% pure ibogaine) orally in capsule form based on body weight and on the type of drug the patient has been using. This medication is non-addictive and is usually administered only once.
Ibogaine is unavailable in the United States due to the ongoing ‘War on Drugs’. Ibogaine cannot be purchased in pharmacies and it cannot be shipped to the United States. We do not sell ibogaine; we only administer ibogaine under the care of a physician.
Ibogaine is a psychedelic drug. A better description of the effects of ibogaine would be oneirophrenic, or “dream creating”. To a bystander it would appear that a person on ibogaine was simply lying down in a state of partial sleep while having dreams. Some patients report their experience as if they were watching a movie of their life, or as if they were able to reorganize the file cabinets in their brains. Every person’s experience is as unique as the individual themself; however, all insights into the subconscious and superconscious mind might be a valuable foundation for a future without drugs. During the weeks after ibogaine treatment people find that they can sort through issues that may have burdened them; change compulsive behaviors; and become receptive to therapy. Not everyone who ingests ibogaine has a vivid visual experience. In fact only about 75% of patients experience visuals. Some people sleep throughout the duration of the drug’s effects, and others experience only a series of rapid thoughts or a succession of flashing lights. The anti-addictive and withdrawal diminishing properties of ibogaine still work on these patients, nonetheless. Ibogaine is non-addictive, although it interacts with the same neurotransmitter receptors in the brain that are related to addiction.